What stage does Serendipity Impact VC invest at?

Serendipity Impact VC invests at the Pre-Seed, Seed, Series A, Series B stages.

Where is Serendipity Impact VC located?

Serendipity Impact VC is headquartered in New York, US.

Who does Serendipity Impact VC co-invest with?

Serendipity Impact VC most often shares deals with Crane Venture Partners, Dag Ventures, Glynn Capital Management, among 16 tracked co-investors.

Serendipity Impact VC

Impact investorActively deploying

New York · Pre-Seed–Series B · 5 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Serendipity Impact VC invests exclusively in technological solutions for mental, neuro, and behavioral health, viewing these as foundational to overall health, longevity, and well-being. The firm engages founders early and takes a hands-on, high-trust approach, acting as co-pilots on product roadmap, go-to-market, first customers, and risk mitigation. It leverages deep networks of clinicians, regulatory experts, and market leaders. Rooted in decades of relationships across the Israeli innovation ecosystem while operating in the U.S. market, the firm helps founders turn breakthrough science into scalable, market-ready solutions for the hardest problems in mental and neuro health.

Invests inBiotech Deep Tech Digital Health Healthtech Impact & Social Good Medical Devices Mental Health Israel New York United States

Source: firm website, verified Aug 11, 2026.

Stage

Pre-Seed–Series B

New York, US

Instruments

Equity

Founded

2024

Tracked investments

Team · 5 people

from the firm's website

Avi Yaron· Co-Founder and Managing Partner· Israelin

Neurotech pioneer and serial entrepreneur with 30+ years in HealthTech. Founder and CEO of Visionsense, a 3D surgical visualization company acquired by Medtronic for $75M, and co-founder and managing partner at HealthYA Ventures. Previously CEO of Joy Ventures and a former lieutenant in Israel's Unit 8200.

Dr. Maria Blekher· Co-Founder and Managing Partner· New Yorkin

Behavioral scientist and venture strategist with 15+ years in U.S. go-to-market strategy and early-stage growth, focused on mental health innovation. Founding Director of the YU Innovation Lab and advisor to mental health ventures, and a connector in the Israeli-U.S. innovation ecosystem.

Sachin Barot· Venture Partner· New Yorkin

Entrepreneur, investor, and advisor with over 20 years bridging Wall Street, venture capital, and health innovation. Focuses on driving impact in mental health and aligning financial returns with human well-being across fintech, health, and mental health tech.

Amit Tobolsky· Investor Relations Director· San Franciscoin

Marketing strategist and brand builder specializing in digital strategy, content, and founder support. Founder and CEO of TOBO.CREATIVE and formerly led marketing strategy at the YU Innovation Lab.

Joe Rollero· Growth Advisor· New Yorkin

Commercial strategist and startup operator with 25+ years scaling surgical technologies. Former commercial lead at Visionsense and founding partner at Med-Connect360, with prior senior leadership roles at Johnson & Johnson.

What they invest in

from 1 of 1 portfolio companies

AI & Machine Learning ×1Cybersecurity ×1Enterprise Software ×1SaaS ×1

Investments · 1 tracked

founders shown can be your intro path

NetCitadelin 𝕏Acquired

Proofpoint provides cybersecurity and compliance software that protects organizations' people, data, cloud environments, and email from advanced cyber threats.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaS

Ashan Willy(CEO)Sumit Dhawan(Chief Executive Officer)Rémi Thomas(Chief Financial Officer)Kim Sullivan(Chief People Officer)Mayank Choudhary(EVP and GM, Information Protection, Cloud Security & Compliance Products Group)Tom Corn(EVP and GM, Threat Protection Group)

Co-investorsCrane Venture Partners Dag Ventures Elevate Ventures Frazier Healthcare Partners Gamut Glynn Capital Management+12 more

Portfolio news

latest coverage across their companies

PromptQL Raises $136 Million To Enhance AI-Powered Virtual Analyst Platform | TradedVC

NetCitadel · traded.co · Jul 9, 2026

Frequently asked questions

What stage does Serendipity Impact VC invest at?: Serendipity Impact VC invests at the Pre-Seed, Seed, Series A, Series B stages.
What sectors does Serendipity Impact VC focus on?: Serendipity Impact VC focuses on Biotech, Deep Tech, Digital Health, Healthtech, Impact & Social Good, Medical Devices, Mental Health.
Where is Serendipity Impact VC located?: Serendipity Impact VC is headquartered in New York, US.
Who does Serendipity Impact VC co-invest with?: Serendipity Impact VC most often shares deals with Crane Venture Partners, Dag Ventures, Glynn Capital Management, among 16 tracked co-investors.

Similar investors

Foreground Capital

Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.

Raisewell Ventures

Raisewell Ventures is a global early to mid-stage venture capital fund bridging Silicon Valley and Southeast Asia, investing in deep tech to pursue both financial returns and economic and social impact.

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.

$250K

HealthQuad

HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.